10:58 AM EDT, 08/26/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were lower late Tuesday morning, declining 0.3% to 1,524.80 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by medical device maker EDAP TMS ( EDAP ) and biopharmaceutical company argenx (ARGX), which advanced 6.4% and 3.2% respectively. They were followed by internet advertising firm Criteo ( CRTO ) and internet browser company Opera (OPRA), which were up 2.9% and 2.8% respectively.

The decliners from continental Europe were led by biotech firm Evaxion ( EVAX ) and pharmaceutical company Novo Nordisk ( NVO ) , which fell 2.9% and 2.5% respectively. They were followed by oil and gas company TotalEnergies (TTE) and petroleum refiner Equinor ( EQNR ) , which were down 1.5% and 1% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics ( SLN ) and biopharmaceutical company NuCana ( NCNA ) , which rose 4.7% and 2.9% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group ( MREO ) and utilities company National Grid ( NGG ) , which increased 0.9% and 0.8% respectively.

The decliners from the UK and Ireland were led by biotech company Trinity Biotech ( TRIB ) , which plummeted 81%, followed by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which lost 3.4%. Tobacco company British American Tobacco ( BTI ) and biopharmaceutical company Akari Therapeutics ( AKTX ) dropped 2.3% and 1.6% respectively.